Log in to save to my catalogue

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immuno...

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immuno...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9007472

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)

About this item

Full title

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)

Publisher

Poland: Wydawnictwo Via Medica

Journal title

Cardiology journal, 2022-04, Vol.29 (2), p.329-341

Language

English

Formats

Publication information

Publisher

Poland: Wydawnictwo Via Medica

More information

Alternative Titles

Full title

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9007472

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9007472

Other Identifiers

ISSN

1897-5593

E-ISSN

1898-018X

DOI

10.5603/CJ.a2021.0166

How to access this item